Table 1.
Baseline Demographic, Clinical Presentation and Laboratory Parameter of HCC Patients Managed with TACE (n = 43).
| Parameter | Value |
|---|---|
| Age (years), mean ± sd | 55.1 ± 12.8 |
| Sex (M:F) | 35:8 |
| Etiology | |
| HBV | 19 (44.2%) |
| HCV | 11 (25.6%) |
| NASH | 4 (9.3%) |
| Alcohol | 4 (9.3%) |
| HBV and alcohol | 3 (7.0%) |
| HBV and HCV co-infection | 1 (2.3%) |
| Cryptogenic | 1 (2.3%) |
| Clinical presentation | |
| Abdominal pain | 20 (46.5%) |
| Weight loss | 19 (44.2%) |
| Fever | 7 (16.3%) |
| Bilirubin (mg/dl) | 1.5 (1.0–2.5) |
| AST (IU/L) | 161 (92–254) |
| ALT (IU/L) | 107 (59–176) |
| Albumin (g/dl) | 3.4 (2.9–3.8) |
| Alkaline phosphatase (IU/L) | 285 (220–421) |
| Sodium (mEq/L) | 134 (132–138) |
| Potassium (mEq/L) | 4.1 (3.7–4.5) |
| Hemoglobin (g/dl) | 10.8 (9.6–12.0) |
| Total leukocyte count (per mm3) | 7500 (5100–9900) |
| Platelet count (×103 per mm3) | 120 (80–148) |
| Creatinine (mg/dl) | 0.9 (0.7–1.0) |
| Alpha-fetoprotein (ng/ml) | 19.1 (5.2–387) |
| INR | 1.3 (1.2–1.4) |
| CTP score | 6 (5–7) |
| MELD | 7.4 (5.4–11.2) |
| MELD-Na | 12.6 (9.2–15.5) |
| ICG-PDR (%/min) | 9.7 (6.7–12.5) |
| ICG-R15 (%) | 23.3 (15.2–36.6) |
All values are expressed as n (%) or median (IQR) unless otherwise specified. Abbreviations: HBV, Hepatitis B Virus; HCV, Hepatitis C Virus; NASH, Non-Alcoholic Steatohepatitis; AST, Aspartate Aminotransferase; ALT, Alanine Aminotransferase; INR, International Normalized Ratio; CTP, Child-Turcotte-Pugh; MELD, model for end stage liver disease; MELD-Na, model for end stage liver disease-sodium; ICG-PDR, indocyanine green-plasma disappearance rate.